Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months

Publisher： Karger

E-ISSN： 1424-8840|33|4|197-201

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.4, 2004-12, pp. : 197-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite

Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis

By  

Cardiology, Vol. 133, Iss. 3, 2016-0 ,pp. : 163-172

Karger

Access to resources Recommend Favorite

Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin versus Unfractionated Heparin in the Treatment of Patients with Acute Pulmonary Thromboembolism

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 440-444

Karger

Access to resources Recommend Favorite

Harmful Medication Errors Involving Unfractionated and Low-Molecular-Weight Heparin in Three Patient Safety Reporting Programs

By Grissinger Matthew C.   Hicks Rodney W.   Keroack Mark A.   Marella William M.   Vaida Allen J.  

Joint Commission Journal on Quality and Patient Safety, Vol. 36, Iss. 5, 2010-05 ,pp. : 195-202

Joint Commission Resources

Access to resources Recommend Favorite